Advanced Search

 

Study ID Status Title Patient Level Data
SMS40093 Completed A multi-centre, randomised, double blind, three limbed, parallel-group study comparing the efficacy and tolerability of salmeterol xinafoate 25?g and 50?g bd with salbutamol 200?g bd given via pressurised inhalers in children with reversible airways obstruction. (Results of the final nine months ...
SMS40097 Completed Long-term treatment of chronic obstructive pulmonary disease with Salmeterol and the additive effect of Ipratropium.
SMS40099 Completed A multicentre, randomised, double-blind, parallel group study to compare the efficacy and safety of inhaled salmeterol xinafoate 50 mg bd and inhaled salmeterol xinafoate 100 mg bd with placebo, all administered via the metered-dose inhaler, in the treatment of patients with…
SMS40124 Completed Prophylactic treatment of exercise-induced asthma in children: salmeterol or sodium cromoglycate single dose before exercise
SMS40138 Completed Comparison of Salmeterol versus other usually prescribed treatments in adults with moderate to severe asthma.
SMS40180 Completed A 12 week study to compare the efficacy and safety of salmeterol xinafoate plus beclomethasone dipropionate with a double dose of beclomethasone dipropionate in patients with mild to moderate reversible airways obstruction treated by a general practitioner.
SMS40221 Completed Comparing the efficacy and safety of inhaled salmeterol 50mcg bid and placebo via Diskus in patients with reversible airway obstruction.
SMS40230 Completed Randomized, double-blind, parallel-group study of 1 week treatment with salmeterol or placebo added tobeclomethasone dipropionate (BDP) on response to allergen challengeExtensive searching has revealed that no clinical report is available for this study. The clinical trial resultswere reported v ...
SMS40238 Completed Salmeterol MDI (50?g b.d) versus Ketotifen capsules (1mg b.d) in patients with bronchial asthma
SMS40241 Completed Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma.
SMS40269 Completed A Two-Month Comparison of Salmeterol / Beclomethasone and Slow-Release Terbutaline / budesonide in Moderate Asthma Management.
SMS40289 Completed Inhaled salmeterol in patients with mild to moderate reversible obstructive airways obstruction. A multicentre, randomized, double-blind, placebo-controlled, cross-over comparison of 50µg salmeterol administered twice daily and 200µg salbutamol administered four times daily.
SMS40290 Completed Inhaled salmeterol in adolescents and adult patients with mild to moderate chronic reversible obstructive airways disease. A multicenter, randomized, double-blind, parallel, comparative clinic trial of twelve week courses of 50µg salmeterol administered twice daily, versus 200µg salbutamol admi ...
SMS40298 Completed A multi-centre, randomized, double-blind, parallel group study to evaluate the impact on Quality of Life (QOL) of adding Serevent 50ug bid via MDI to patients’ existing therapy in patients with chronic obstructive pulmonary disease (COPD).
SMS40308 Completed A randomised, double-blind, double-dummy, placebo-controlled, parallel-group, multicenter study to compare efficacy and tolerability of salmeterol (50 µg b.i.d., Serevent® Diskus®) and a combination of…
SMS40309 Completed An multicentre randomised, double-blind, double-dummy, cross-over study to assess the safety and tolerability of salmeterol (50 µg) via DiskusTM and formoterol (12 µg and 24 µg) via TurbohalerTM in co-morbid adults with mild to moderate chronic obstructive pulmonary disease and coronary heart di ...
SMS40314 Completed A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, 8-Week Comparison of Salmeterol Xinafoate Versus Ipratropium Bromide Versus Salmeterol Xinafoate Plus Ipratropium Bromide Versus Placebo in Subjects With Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
SMS40315 Completed A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel Group, 8-Week Comparison of Salmeterol Xinafoate Versus Ipratropium Bromide Versus Salmeterol Xinafoate Plus Ipratropium Bromide Versus Placebo in Subjects With Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
SMS40318 Completed Randomized, double blind, placebo-controlled, parallel-group trial over 4 weeks to evaluate the effect of salmeterol (2x50 µg/d by Diskus®) on the lung volumes at rest and during sub-maximal exercise in subjects with moderate chronic obstructive pulmonary disease (COPD)
SMS40320 Completed A Multi-Center, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of Salmeterol Xinafoate Inhalation Aerosol Versus Ipratropium Bromide and Albuterol Sulfate Inhalation Aerosol in Subjects With Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
SMS40321 Completed A Multi-Center, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of Salmeterol Xinafoate Inhalation Aerosol Versus Ipratropium Bromide and Albuterol Sulfate Inhalation Aerosol in Subjects With Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
SMS40329 Completed A Randomised, Single-Blind, Parallel-Group, 28-Day, Pilot Study to Compare the Addition of Inhaled Salmeterol 50µg bid (via the DISKHALER™ Inhaler) or Tulobuterol-Patch 2mg qd Nocte in Adult Asthmatic Subjects who are Symptomatic on Inhaled Corticosteroids Alone Study Listed on ClinicalStudyDataRequest.com
SMS40330 Completed A Randomized, Multi-Center, Cross Over Comparison of Salmeterol Xinafoate Inhalation Powder (50mcg BID) via the DISKUS ™ and Salmeterol Xinafoate Inhalation Aerosol (42mcg BID) via the Metered Dose Inhaler on Measures of Device Preference in Subjects with COPD Study Listed on ClinicalStudyDataRequest.com
SMS40332 Completed A randomised, open-label, parallel group 28-day pilot study to compare the addition of inhaled salmeterol 50mcg b.i.d. (via the DISKHALER inhaler) or tulobuterol patch 2mg once daily nocte in adult asthmatic subjects symptomatic on treatment with inhaled corticosteroids. Study Listed on ClinicalStudyDataRequest.com
SMT-06-91 Completed Double blind, placebo-controlled, cross-over study to assess the safety and efficacy of repeated oral doses of sumatriptan (GR43175C) 100mg (plus two optional oral doses of sumatriptan (GR43175C) 100mg) in the acute treatment of migraine.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.